{"id":85676,"date":"2026-05-12T18:23:09","date_gmt":"2026-05-12T12:53:09","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=85676"},"modified":"2026-05-12T18:23:12","modified_gmt":"2026-05-12T12:53:12","slug":"piramal-pharma-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/","title":{"rendered":"Piramal Pharma Share Price Target 2026: Expert Forecast, Catalysts and Key Risks"},"content":{"rendered":"<div class=\"meta-block\">\u00a0<\/div>\n<p>The <strong><a href=\"https:\/\/univest.in\/user\/stocks\/pplpharm\/piramal-pharma-ltd-share-price-today\">Piramal Pharma<\/a> share price target<\/strong> for 2026 stands at Rs 267 as per analyst forecast implying 20 to 40 percent upside from the current market price of Rs 220. Investors tracking the <strong>Piramal Pharma share price target 2026<\/strong> need to understand the full picture including growth catalysts, FY27 earnings timeline, key risks, and the bull vs bear case scenarios. This article covers every dimension of the <strong>Piramal Pharma share price target<\/strong> thesis updated April 2026.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here Get Free Investment Predictions on Univest<\/strong><\/a><\/p>\n<p>Track live Piramal Pharma price, FII\/DII flows and analyst targets on the <strong>Univest Screener<\/strong>.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Piramal_Pharma_Company_Overview\" title=\"Piramal Pharma Company Overview\">Piramal Pharma Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Why_Is_Piramal_Pharma_Share_Price_Target_Set_at_Rs_267_for_2026\" title=\"Why Is Piramal Pharma Share Price Target Set at Rs 267 for 2026\">Why Is Piramal Pharma Share Price Target Set at Rs 267 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#FY27_Earnings_Delivery_and_Revenue_Acceleration\" title=\"FY27 Earnings Delivery and Revenue Acceleration\">FY27 Earnings Delivery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Structural_Sector_Tailwinds_in_Pharmaceuticals_CDMO_Consumer_Health\" title=\"Structural Sector Tailwinds in Pharmaceuticals CDMO Consumer Health\">Structural Sector Tailwinds in Pharmaceuticals CDMO Consumer Health<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Improving_Macro_Backdrop\" title=\"RBI Rate Cut Cycle and Improving Macro Backdrop\">RBI Rate Cut Cycle and Improving Macro Backdrop<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Union_Budget_2026_Policy_Support\" title=\"Union Budget 2026 Policy Support\">Union Budget 2026 Policy Support<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Improving_FII_Flows_Post_US_Tariff_Shock\" title=\"Improving FII Flows Post US Tariff Shock\">Improving FII Flows Post US Tariff Shock<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Piramal_Pharma_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\" title=\"Piramal Pharma Share Price Targets Short Term 12 Month and Long Term\">Piramal Pharma Share Price Targets Short Term 12 Month and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Short_Term_Piramal_Pharma_Share_Price_Target_3_to_6_Months\" title=\"Short Term Piramal Pharma Share Price Target 3 to 6 Months\">Short Term Piramal Pharma Share Price Target 3 to 6 Months<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#12_Month_Piramal_Pharma_Share_Price_Target_2026\" title=\"12 Month Piramal Pharma Share Price Target 2026\">12 Month Piramal Pharma Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Long_Term_Piramal_Pharma_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Piramal Pharma Share Price Target FY27 to FY28\">Long Term Piramal Pharma Share Price Target FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Bull_Case_and_Bear_Case_for_Piramal_Pharma_Share_Price_Target\" title=\"Bull Case and Bear Case for Piramal Pharma Share Price Target\">Bull Case and Bear Case for Piramal Pharma Share Price Target<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Bull_Case_Piramal_Pharma_Share_Price_Target_Rs_343\" title=\"Bull Case Piramal Pharma Share Price Target Rs 343\">Bull Case Piramal Pharma Share Price Target Rs 343<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Bear_Case_Piramal_Pharma_Share_Price_Target_Rs_163\" title=\"Bear Case Piramal Pharma Share Price Target Rs 163\">Bear Case Piramal Pharma Share Price Target Rs 163<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Key_Risks_to_the_Piramal_Pharma_Share_Price_Target_2026\" title=\"Key Risks to the Piramal Pharma Share Price Target 2026\">Key Risks to the Piramal Pharma Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#US_Tariff_Macro_Headwind\" title=\"US Tariff Macro Headwind\">US Tariff Macro Headwind<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Valuation_and_Earnings_Miss_Risk\" title=\"Valuation and Earnings Miss Risk\">Valuation and Earnings Miss Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Competitive_Pressure_in_Pharmaceuticals_CDMO_Consumer_Health\" title=\"Competitive Pressure in Pharmaceuticals CDMO Consumer Health\">Competitive Pressure in Pharmaceuticals CDMO Consumer Health<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#FII_Selling_Pressure_and_Currency_Risk\" title=\"FII Selling Pressure and Currency Risk\">FII Selling Pressure and Currency Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#How_to_Invest_in_Piramal_Pharma\" title=\"How to Invest in Piramal Pharma\">How to Invest in Piramal Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#FAQs_on_Piramal_Pharma_Share_Price_Target_2026\" title=\"FAQs on Piramal Pharma Share Price Target 2026\">FAQs on Piramal Pharma Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#What_is_the_Piramal_Pharma_share_price_target_for_2026\" title=\"What is the Piramal Pharma share price target for 2026?\">What is the Piramal Pharma share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Is_Piramal_Pharma_a_good_buy_at_CMP_Rs_220\" title=\"Is Piramal Pharma a good buy at CMP Rs 220?\">Is Piramal Pharma a good buy at CMP Rs 220?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#What_are_the_main_risks_to_the_Piramal_Pharma_share_price_target\" title=\"What are the main risks to the Piramal Pharma share price target?\">What are the main risks to the Piramal Pharma share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#What_are_the_key_catalysts_for_the_Piramal_Pharma_share_price_target\" title=\"What are the key catalysts for the Piramal Pharma share price target?\">What are the key catalysts for the Piramal Pharma share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#What_is_the_Piramal_Pharma_share_price_target_for_2027\" title=\"What is the Piramal Pharma share price target for 2027?\">What is the Piramal Pharma share price target for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Where_can_I_track_Piramal_Pharma_live_analyst_targets\" title=\"Where can I track Piramal Pharma live analyst targets?\">Where can I track Piramal Pharma live analyst targets?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#What_is_Piramal_Pharma_52_week_high_and_low\" title=\"What is Piramal Pharma 52 week high and low?\">What is Piramal Pharma 52 week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#How_to_buy_Piramal_Pharma_shares\" title=\"How to buy Piramal Pharma shares?\">How to buy Piramal Pharma shares?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/piramal-pharma-share-price-target-2026\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Company_Overview\"><\/span><strong>Piramal Pharma Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/a><\/p>\n<p>Piramal Pharma (NSE: PPLPHARMA) is a listed company in India&#8217;s Pharmaceuticals CDMO Consumer Health sector with a market capitalisation of Rs 12,000 crore. At CMP Rs 220 against a 52 week range of Rs 165 to Rs 320, the stock currently offers meaningful upside to the analyst forecast <strong>Piramal Pharma share price target<\/strong> of Rs 267. For more share price target analysis, visit <a href=\"https:\/\/univest.in\/blogs\"><strong>Univest Blogs<\/strong><\/a>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>PPLPHARMA<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceuticals CDMO Consumer Health<\/td>\n<\/tr>\n<tr>\n<td>CMP April 2026<\/td>\n<td>Rs 220<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 320<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 165<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 12,000 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>55x<\/td>\n<\/tr>\n<tr>\n<td>12M Analyst Target<\/td>\n<td>Rs 267<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 343<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 163<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_Piramal_Pharma_Share_Price_Target_Set_at_Rs_267_for_2026\"><\/span><strong>Why Is Piramal Pharma Share Price Target Set at Rs 267 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Delivery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Delivery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>FY27 is the year where analysts expect Piramal Pharma to deliver meaningful PAT growth. This is the primary variable that bridges the gap between the current CMP of Rs 220 and the <strong>Piramal Pharma share price target 2026<\/strong> of Rs 267. Analysts project 15 to 20 percent PAT growth in FY27. Q4 FY26 results with positive FY27 guidance are the immediate trigger for re-rating toward the <strong>Piramal Pharma share price target<\/strong> forecast. Track Q4 results live on the <strong>Univest Screener<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Sector_Tailwinds_in_Pharmaceuticals_CDMO_Consumer_Health\"><\/span><strong>Structural Sector Tailwinds in Pharmaceuticals CDMO Consumer Health<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s Pharmaceuticals CDMO Consumer Health sector is expanding at 12 to 18 percent annually driven by urbanisation, rising incomes, government policy continuity, and the broad India growth narrative. Piramal Pharma&#8217;s market position within this expanding sector creates compounding runway that directly supports the <strong>Piramal Pharma share price target<\/strong> forecast of Rs 267. Discover top stocks on the <strong>Univest Screener<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Improving_Macro_Backdrop\"><\/span><strong>RBI Rate Cut Cycle and Improving Macro Backdrop<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle which commenced in 2026 reduces Piramal Pharma&#8217;s borrowing costs and stimulates end customer demand. Lower interest rates improve EBITDA to PAT conversion, directly expanding EPS and supporting the <strong>Piramal Pharma share price target 2026<\/strong> of Rs 267. Compare Piramal Pharma with sector peers live on the <strong>Univest Screener<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026_Policy_Support\"><\/span><strong>Union Budget 2026 Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Union Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex, continued PLI scheme support, and consumption demand incentives create a positive policy backdrop for Piramal Pharma&#8217;s Pharmaceuticals CDMO Consumer Health business, directly supporting the <strong>Piramal Pharma share price target 2026<\/strong> bull case.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Improving_FII_Flows_Post_US_Tariff_Shock\"><\/span><strong>Improving FII Flows Post US Tariff Shock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As macro conditions normalise post the April 2026 US tariff shock, FII flows into quality Indian companies are expected to recover through FY27, directly supporting the <strong>Piramal Pharma share price target<\/strong> of Rs 267. Track live FII\/DII activity on the <strong>Univest Screener<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Piramal Pharma Share Price Targets Short Term 12 Month and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to get daily stock recommendations and SEBI registered research.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Piramal_Pharma_Share_Price_Target_3_to_6_Months\"><\/span><strong>Short Term Piramal Pharma Share Price Target 3 to 6 Months<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The short term <strong>Piramal Pharma share price target<\/strong> is anchored to the 52 week low support zone near Rs 165. Subscribe to <a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Univest Pro<\/strong><\/a> for SEBI registered entry, target, and stop loss recommendations on Piramal Pharma.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12_Month_Piramal_Pharma_Share_Price_Target_2026\"><\/span><strong>12 Month Piramal Pharma Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12 month analyst forecast <strong>Piramal Pharma share price target 2026<\/strong> is Rs 267 implying 20 to 40 percent upside from CMP Rs 220. Track live targets on the <strong>Univest Screener<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Piramal_Pharma_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Piramal Pharma Share Price Target FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>For investors with a 2 to 3 year horizon, the long term <strong>Piramal Pharma share price target<\/strong> is Rs 343 in the bull case. For more analysis, visit <a href=\"https:\/\/univest.in\/blogs\"><strong>Univest Blogs<\/strong><\/a>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_for_Piramal_Pharma_Share_Price_Target\"><\/span><strong>Bull Case and Bear Case for Piramal Pharma Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Piramal_Pharma_Share_Price_Target_Rs_343\"><\/span><strong>Bull Case Piramal Pharma Share Price Target Rs 343<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bull case for the <strong>Piramal Pharma share price target<\/strong> of Rs 343 materialises if FY27 earnings exceed forecast and the Pharmaceuticals CDMO Consumer Health sector benefits from a broad FII driven re-rating. Discover top stocks and live analyst targets on the <strong>Univest Screener<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Piramal_Pharma_Share_Price_Target_Rs_163\"><\/span><strong>Bear Case Piramal Pharma Share Price Target Rs 163<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bear case sees the <strong>Piramal Pharma share price target<\/strong> testing Rs 163 if FY27 guidance disappoints significantly and FII outflows from India persist. Track support levels on the <strong>Univest Screener<\/strong>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Price Target<\/th>\n<th>Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 343<\/td>\n<td>FY27 beat, macro normalisation, sector re-rating, strong FII inflows<\/td>\n<\/tr>\n<tr>\n<td>Base Case Forecast<\/td>\n<td>Rs 267<\/td>\n<td>In line FY27 earnings, tariff resolution, FII recovery to neutral<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 163<\/td>\n<td>FY27 guidance cut, persistent FII outflows, sector de-rating<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Piramal_Pharma_Share_Price_Target_2026\"><\/span><strong>Key Risks to the Piramal Pharma Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"US_Tariff_Macro_Headwind\"><\/span><strong>US Tariff Macro Headwind<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 26 percent US reciprocal tariff announced April 2, 2026 created FII outflow pressure across all Indian equities including Piramal Pharma. This is the key downside risk to the <strong>Piramal Pharma share price target 2026<\/strong> forecast of Rs 267. Monitor trade developments live on the <strong>Univest Screener<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_and_Earnings_Miss_Risk\"><\/span><strong>Valuation and Earnings Miss Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 55x P\/E, Piramal Pharma is priced for consistent execution. Any earnings miss or guidance cut creates disproportionate de-rating risk, the most immediate risk to the <strong>Piramal Pharma share price target 2026<\/strong> of Rs 267. Track earnings on the <strong>Univest Screener<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Pressure_in_Pharmaceuticals_CDMO_Consumer_Health\"><\/span><strong>Competitive Pressure in Pharmaceuticals CDMO Consumer Health<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Intensifying competition in Pharmaceuticals CDMO Consumer Health may compress Piramal Pharma&#8217;s pricing power and market share over the medium term. Subscribe to <a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Univest Pro<\/strong><\/a> for SEBI registered research on Piramal Pharma.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Selling_Pressure_and_Currency_Risk\"><\/span><strong>FII Selling Pressure and Currency Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Global risk off events can trigger institutional selling, disconnecting price from fundamental value. Track live FII\/DII flows on the <strong>Univest Screener<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Piramal_Pharma\"><\/span><strong>How to Invest in Piramal Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li><strong>Research on Univest Screener:<\/strong> Search PPLPHARMA at <a href=\"https:\/\/univest.in\/screeners\">univest.in\/screeners<\/a> for live fundamentals and the latest <strong>Piramal Pharma share price target<\/strong> data.<\/li>\n<li><strong>Open a Demat Account:<\/strong> Buy Piramal Pharma (PPLPHARMA) through any SEBI registered broker. <a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Start on Univest here<\/strong><\/a>.<\/li>\n<li><strong>Plan Your Entry:<\/strong> Key support near Rs 165. First resistance at the lower bound of the <strong>Piramal Pharma share price target<\/strong> range of Rs 267.<\/li>\n<li><strong>Position Sizing:<\/strong> Allocate maximum 3 to 5 percent of your portfolio to any single stock.<\/li>\n<li><strong>Monitor:<\/strong> Download the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest App<\/a> for SEBI registered analyst research alerts on the <strong>Piramal Pharma share price target<\/strong>.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Piramal_Pharma_Share_Price_Target_2026\"><\/span><strong>FAQs on Piramal Pharma Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Piramal_Pharma_share_price_target_for_2026\"><\/span><strong>What is the Piramal Pharma share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Piramal Pharma share price target 2026<\/strong> is Rs 267 based on analyst forecast. Bull case is Rs 343, bear case is Rs 163. Track live on the <strong>Univest Screener<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Piramal_Pharma_a_good_buy_at_CMP_Rs_220\"><\/span><strong>Is Piramal Pharma a good buy at CMP Rs 220?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At Rs 220, Piramal Pharma offers potential upside to the <strong>Piramal Pharma share price target 2026<\/strong> of Rs 267. Depends on your risk tolerance and horizon. <a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Get free research on Univest<\/strong><\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_risks_to_the_Piramal_Pharma_share_price_target\"><\/span><strong>What are the main risks to the Piramal Pharma share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks to the <strong>Piramal Pharma share price target<\/strong> of Rs 267 include US tariff macro headwinds, valuation at 55x P\/E, competitive dynamics in Pharmaceuticals CDMO Consumer Health, and FII selling. Track on the <strong>Univest Screener<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_catalysts_for_the_Piramal_Pharma_share_price_target\"><\/span><strong>What are the key catalysts for the Piramal Pharma share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Primary catalysts for the <strong>Piramal Pharma share price target 2026<\/strong> include Q4 FY26 results with positive FY27 guidance, RBI rate cuts, Union Budget policy support, and FII flow recovery. Track live on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Piramal_Pharma_share_price_target_for_2027\"><\/span><strong>What is the Piramal Pharma share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>For FY27 to FY28, analysts project the <strong>Piramal Pharma share price target<\/strong> toward Rs 343 in the bull case. Consult a SEBI registered financial advisor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Piramal_Pharma_live_analyst_targets\"><\/span><strong>Where can I track Piramal Pharma live analyst targets?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Track the <strong>Piramal Pharma share price target<\/strong> live at <a href=\"https:\/\/univest.in\/screeners\"><strong>univest.in\/screeners<\/strong><\/a>. Download the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> or <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Piramal_Pharma_52_week_high_and_low\"><\/span><strong>What is Piramal Pharma 52 week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Piramal Pharma&#8217;s 52 week high is Rs 320 and 52 week low is Rs 165. The current CMP of Rs 220 offers potential upside to the analyst forecast <strong>Piramal Pharma share price target 2026<\/strong> of Rs 267.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_to_buy_Piramal_Pharma_shares\"><\/span><strong>How to buy Piramal Pharma shares?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Buy Piramal Pharma (PPLPHARMA) through any SEBI registered broker on NSE. Research the <strong>Piramal Pharma share price target<\/strong> on the <strong>Univest Screener<\/strong> and download the Univest App for SEBI registered analyst research alerts.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available data as of April 2026. Consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/why-is-ahlucont-share-price-falling-key-reasons-2026\">Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-ahlucont-share-price-falling-key-reasons-2026\">Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-nuvoco-share-price-falling-key-reasons-2026\">Why Is Nuvoco Vistas Corporation Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-capacite-share-price-falling-key-reasons-2026\">Why Is Capacite Infraprojects Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-psp-projects-share-price-falling-key-reasons-2026\">Why Is PSP Projects Share Price Falling Key Reasons 2026<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Piramal Pharma share price target 2026 is Rs 267. Analyst forecast, bull case Rs 343, bear case Rs 163. Catalysts, risks and full analysis. April 2026.<\/p>\n","protected":false},"author":26,"featured_media":86041,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-85676","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1778590421:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["79"],"rank_math_focus_keyword":["Piramal Pharma Share Price Target"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Piramal Pharma Share Price Target 2026 Forecast"],"rank_math_description":["Piramal Pharma share price target 2026 is Rs 267. Analyst forecast, bull case Rs 343, bear case Rs 163. Catalysts, risks and full analysis. April 2026."],"_thumbnail_id":["86041"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["11085"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/12182240\/Piramal-Pharma-Share-Price-Target-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/85676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=85676"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/85676\/revisions"}],"predecessor-version":[{"id":86042,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/85676\/revisions\/86042"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/86041"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=85676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=85676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=85676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}